
Our stories
/
News & Perspectives
/
Bristol Myers Squibb Receives an FDA Approval
Lung Cancer
Bristol Myers Squibb Receives an FDA Approval

September 15, 2020
Â© 2024
Bristol-Myers Squibb Company